A selective PIKfyve inhibitor blocks PtdIns(3,5)P2production and disrupts endomembrane transport and retroviral budding

Author:

Jefferies Harold B J1,Cooke Frank T2,Jat Parmjit3,Boucheron Christine1,Koizumi Tomonobu4,Hayakawa Masahiko4,Kaizawa Hiroyuki4,Ohishi Takahide4,Workman Paul5,Waterfield Michael D6,Parker Peter J17

Affiliation:

1. London Research Institute Cancer Research UK, Lincoln's Inn Fields Laboratories 44 Lincoln's Inn Fields London WC2A 3PX UK

2. Department of Biochemistry and Molecular Biology, University College London Gower Street London WC1E 6BT UK

3. Department of Neurodegenerative Disease, Institute of Neurology, University College London Queen Square London WC1N 3BG UK

4. Institute for Drug Discovery Research, Astellas Pharma Inc 21 Miyukigoaka Tsukuba Ibaraki 305‐8585 Japan

5. Cancer Research UK Centre for Cancer Therapeutics, Institute of Cancer Research Sutton Surrey SN2 5NG UK

6. Proteomics Unit, Wolfson Institute for Biomedical Research, University College Gower Street London WC1E 6BT UK

7. The Division of Cancer Studies, King's College School of Medicine St Thomas Street London SE1 1UL UK

Publisher

EMBO

Subject

Genetics,Molecular Biology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3